OncoAlert

The OncoAlert WEEKLY RoundUp 🚨 Covering the TOP of the week July 11-17, 2025 👉REGISTER at OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoale… Discussing: ✅TALAPRO2 in #ProstateCancer ✅Geriatric Assessment 👴 ✅Molecular Landscape of Non Clear Cell Renal Carcinoma…

💥 Another #OncoAlert WEEKLY RoundUp! 🔥 oncoalert.m-pages.com/nhMpwe/oncoale… From TALAPRO2 & Geriatric Assessments to ACCORD in #Cholangiocarcinoma & Microbiome modulation—don’t miss what’s shaping the week in #Oncology 🧬 👀 Catch the full rundown 👇 @OncoAlert

The OncoAlert WEEKLY RoundUp 🚨 Covering the TOP of the week July 11-17, 2025 REGISTER at OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoale… @VJOncology @COR2EDMedEd @high5md @mirrorsmed @wearemedsir @JournalCancer

Congrats to rising star @coskunyazgann and every colleague on this great study tackling a real clinical question for patients with mCRPC. Curiosity, teamwork, and care move science forward. Proud of our team’s work! #Oncology #ProstateCancer @OncJournal @APCCC_Lugano @OncoAlert…

When do you test for c-MET? Diagnosis? Disease progression? Answer the polling question below to help us learn from your practice at #BTGLung2025 @OncBrothers @OncoAlert @OncLive

This year’s Uromigos Cup is America 🇺🇸 🇨🇦 vs Eurasia 🇯🇵 🇨🇳 🇦🇺 🇪🇺 . Eurasia is already 1-0 ahead after winning the darts 🎯 at the Uromigos party. Here @montypal starts to pick his americas team in this multidisciplinary and wide ranging competition. It will finish at the…

"Identifying those who don’t need radical surgery is key." - Dr. Linda Duska (@LDuska) 🎙️ A recent episode of CancerSpeak dives into the latest advances in #CervicalCancer research. Catch the full episode here: cancerspeak.podbean.com/e/top-advances… @oncoalert @uvahealthnews #gyncsm

Urgent progress needed: Pancreatic cancer remains the 3rd leading cause of cancer death in the US according to 2025 @AmericanCancer report. Both incidence and mortality rates are rising, with a 5-year survival of just 8% for most patients. 🔗 acsjournals.onlinelibrary.wiley.com/doi/full/10.33… @OncoAlert

Revisit this review article led by @AmyWisdom8 of @harvardradonc | Clinician's primer for soft tissue sarcomas: Nuances of histologic subtypes acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert @chandrajitraut @candace_haddox @JLHornick @corrie_painter

Another excellent @weoncologists summary of the @OncoAlert round-up 🤠 #SuppOnc Includes updated data from @CACancerJournal on #GA the pillar assessment for #olderadults #GIonc includes #agnostic treatments in #dMMR cancer 🧬 Be sure to not miss an update by signing up 🔗:…

Ongoing #video summaries of the #Top10Tips paper for #hpm on #survonc published in @PalliativeMed_j Presenting Tip 6⃣ #ChronicPain and #Opioid therapy @GreggWeltyMD @DrN_CancerPCP @DrNicolasHart @doc_martin19 @BillyRosaPhD @OncoAlert🚨 @PallOncCoP #OncoAlertAF @yekeduz_emre…

The Post-ASCO 2025 GU Cancer Highlights virtual webinar by @VJOncology WATCH NOW On Demand 👉 bit.ly/3UmZI7Q Featuring expert presentations and discussions on key GU cancer abstracts from ASCO 2025. @neerajaiims @ERPlimackMD @AndreaNecchi

Disparities in receipt of palliative-intent treatment among disaggregated Hispanic populations with breast, lung, and #ProstateCancer in the United States🇺🇸 acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… Study reveals significant disparities in the receipt of palliative-intent interventions among…

Exercise in patients with metastatic prostate cancer: A comprehensive review cancertreatmentreviews.com/article/S0305-… Physical activity🏃 and structured exercise have been shown to significantly improve quality of life in #ProstateCancer (PC) patients, particularly by alleviating side effects…

A global #SuppOnc study in @PsyOnc from @crisbergerot N=1,105 cancer patients in 🇧🇷 and 🇲🇽 Brazilians ⬆️ anxiety 😨 Mexicans ⬆️ depression 😭 Gender, age, and stage were 🔑 factors. Culturally tailored support is urgently needed in #LATAM 🔗: onlinelibrary.wiley.com/doi/10.1002/po……

🔬Epithelial–mesenchymal transition (EMT) and cancer: what clinicians should know @NatRevClinOncol ✅Excellent review ✅Mechanism, clinical evidence, biomarkers, treatment strategies, ongoing trials, challenges 👉nature.com/articles/s4157… #cancer #oncology #MedX @OncoAlert

@OncoAlert

Out in one of our partner Journals @CACancerJournal Personalized care for patients with EGFR-mutant nonsmall cell lung cancer: Navigating early to advanced disease management buff.ly/vv1ol7z The discovery of EGFR 🧬 mutations has transformed the treatment of…

Biagio, it will be an honor to welcome you to our institution. I'll be on vacation, but you'll be warmly welcomed! @BRicciutiMD @OncoAlert #LCSM

NEOIPOWER (@LungCaJournal): In resectable stage II–IIIB #EGFR+ NSCLC, neoadjuvant icotinib + chemo led to an ORR of 83.3%, but MPR was just 6.7% with no pCR. Adds to growing evidence of limited pathologic response w/ TKIs in this setting.🚨 @OncoAlert lungcancerjournal.info/article/S0169-…

The rise of China’s pharmaceutical industry from 2015–2024: a decade of innovation nature.com/articles/d4157… @OncoAlert @LungCancerRx